Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2017-03-01
2020-01-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A substudy of this larger study ( Effects of Gentle Jogger on blood pressure), will determine the effects of 30 min of gentle jogger in seated and supine posture compared to Sham
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise and Prevention of Syncope: EXPOSE
NCT00203593
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
NCT05712395
Effects of a Suspension Training Warm-up on Cardiopulmonary Exercise Performance
NCT07215052
Reducing Older Adults' Sedentary Behavior by Self-monitoring
NCT04003324
Whole Body Vibration Combined With L-citrulline Supplementation on Cardiovascular Function and Body Composition
NCT02143817
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will also be recruited for a sub-study of the above larger study. This sub-study will determine the effects of a single device Gentle Jogger in setaed and supine posture over a 30 min period on continuously measured non-invasive blood pressure, and compared the latter to SHAM. On day 1 Subjects will be randomized to begin in seated or supine posture with 30 min of SHAM, and 30 min of Gentle Jogger, 3 days latter the subject will cross over to start with the opposite posture of day 1.
This study will determine the effects of 30 min of sedentary supine or seated (SHAM) and the effects of 30 min of G. Jogger in these two postures on continuous noninvasive measured blood pressure
Volunteers will be paid for their participation in the study The Gentle Jogger and Gentle Jumper are non-FDA regulated wellness devices (2016) in which, 1) GJogger and GJumper as part of a healthy lifestyle may help to prevent certain chronic diseases or conditions such as heart disease, high blood pressure, and type 2 diabetes and, 2) may help living well with certain chronic diseases or conditions such as s heart disease, high blood pressure, and type 2 diabetes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
YG ( 25-59yrs) -GJogger
Gentle Jogger applied to each individual in 1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
Gentle Jogger
Passive Simulated Jogging device (Gentle Jogger)
OG (Greater than 60 yrs)-GJogger
Gentle Jogger applied to each individual in (1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
Gentle Jogger
Passive Simulated Jogging device (Gentle Jogger)
YG ( 25-59yrs) -GJumper
Gentle Jumper applied to each individual in 1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
Gentle Jumper
Passive Simulated Jumping Device ( Gentle Jumper)
OG (Greater than 60 yrs)-Gjumper
Gentle Jumper applied to each individual in 1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
Gentle Jumper
Passive Simulated Jumping Device ( Gentle Jumper)
YG ( 25-59yrs) -GJogger Sham
A Sham Gentle Jogger is applied to each individual in 1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
Gentle Jogger
Passive Simulated Jogging device (Gentle Jogger)
OG (Greater than 60 yrs)- GJogger-Sham
A Sham Gentle Jogger is applied to each individual in 1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
Gentle Jogger
Passive Simulated Jogging device (Gentle Jogger)
YG ( 25-59yrs) -GJumper- Sham
A Sham Gentle Jumper is applied to each individual in 1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
Gentle Jumper
Passive Simulated Jumping Device ( Gentle Jumper)
OG (Greater than 60 yrs)-GJumper Sham
A Sham Gentle Jumper is applied to each individual in 1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
Gentle Jumper
Passive Simulated Jumping Device ( Gentle Jumper)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gentle Jogger
Passive Simulated Jogging device (Gentle Jogger)
Gentle Jumper
Passive Simulated Jumping Device ( Gentle Jumper)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to provide Informed Consent
Exclusion Criteria
* Not able to provide informed consent
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sackner Wellness Products LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jose A Adams, M.D.
Role: PRINCIPAL_INVESTIGATOR
Sackner Wellness Products LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CIC Miami
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Adams JA, Lopez JR, Nadkarni V, Zolkipli-Cunningham Z, Ischiropoulos H, Sackner MA. The effects of a motorized passive simulated jogging device on descent of the arterial pulse waveform dicrotic notch: A single arm placebo-controlled cross-over trial. Physiol Rep. 2022 Aug;10(15):e15418. doi: 10.14814/phy2.15418.
Sackner MA, Patel S, Adams JA. Changes of blood pressure following initiation of physical inactivity and after external addition of pulses to circulation. Eur J Appl Physiol. 2019 Jan;119(1):201-211. doi: 10.1007/s00421-018-4016-7. Epub 2018 Oct 22.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20170208
Identifier Type: OTHER
Identifier Source: secondary_id
GJHP2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.